CID 3066926

Piperazine, 1-(3,7-dimethoxydibenzo(b,f)thiepin-10-yl)-4-methyl-, (z)-2-butenedioate (1:1)

Structural Information

Molecular Formula
C21H24N2O2S
SMILES
CN1CCN(CC1)C2=CC3=C(C=C(C=C3)OC)SC4=C2C=CC(=C4)OC
InChI
InChI=1S/C21H24N2O2S/c1-22-8-10-23(11-9-22)19-12-15-4-5-16(24-2)13-20(15)26-21-14-17(25-3)6-7-18(19)21/h4-7,12-14H,8-11H2,1-3H3
InChIKey
JVFJSKUUIOFKMK-UHFFFAOYSA-N
Compound name
1-(2,9-dimethoxybenzo[b][1]benzothiepin-5-yl)-4-methylpiperazine
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

0
Patents

368.15585 Da
Monoisotopic Mass

4.1
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 369.163126 188.5
[M+Na]+ 391.145068 194.9
[M-H]- 367.148574 194.7
[M+NH4]+ 386.189673 200.2
[M+K]+ 407.119008 193.8
[M+H-H2O]+ 351.153110 180.0
[M+HCOO]- 413.154051 198.4
[M+CH3COO]- 427.169701 197.0
[M+Na-2H]- 389.130516 189.6
[M]+ 368.15530142 188.0
[M]- 368.15639858 188.0
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.